← Back to Search

Web-based HIV Prevention Toolkit for HIV

N/A

Waitlist Available

Led By Jason W Mitchell, PhD

Research Sponsored by Florida International University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 3-months, 3-months to 6-months, and baseline to 6-months

Awards & highlights

No Placebo-Only Group

Summary

This trial will research if a digital intervention can help couples stay healthy by using evidence-based strategies and tailored plans.

Who is the study for?

This trial is for cisgender male couples in Lima, Peru who have been in a relationship for over 3 months and are at least 18 years old. They must have had anal sex recently, not experienced partner violence, be willing to test for HIV/STIs, and own a web-connected device.

What is being tested?

The study tests 'Para ti, para mi, para nosotros (P3),' a digital HIV/STI prevention toolkit designed for male couples. It aims to see if the program increases use of proven prevention strategies compared to those on a waitlist.

What are the potential side effects?

Since this intervention is web-based focusing on education and behavior change rather than medication or medical procedures, traditional physical side effects are not expected.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 3-months, 3-months to 6-months, and baseline to 6-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 3-months, 3-months to 6-months, and baseline to 6-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 3-months, 3-months to 6-months, and baseline to 6-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in HIV incidence by comparing results from testing at baseline to 6-months.

Change in STI incidence by comparing results from testing at baseline to 6-months.

Changes in adherence to agreement by comparing responses from baseline to 3-months, 3-months to 6-months, and baseline to 6-months.

+5 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Waitlist ControlExperimental Treatment1 Intervention

From baseline to 3-months, participants in the waitlist control condition will have access to the P3 web app for post-baseline assessment of 3 months and the resources section. From 3 months to 6 months, participants randomized to the waitlist control arm will then have access to the P3 web app intervention and all of its contents (5 modules, resources, etc.), including post-baseline assessment that will occur at 6 months.

Group II: InterventionExperimental Treatment1 Intervention

From baseline to 6 months, participants randomized to the intervention arm will have access to the P3 web app intervention and all of its contents (5 modules, resources, etc.), including post-baseline assessments that will occur at 3 months and 6 months.

Do I qualify?Apply below to find out